U.S. MEIBOMIAN GLAND DYSFUNCTION MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

U.S. Meibomian Gland Dysfunction Market, By Drug Type (Cyclosporine, Omega-3 supplements, Antibacterial eye drops, Steroids, AZR MD 001, TP 03, NOV03 (Novatears), HY02 - Minocycline), By Route of Administration (Oral, Topical), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)

Published In: 27 Apr, 2026
Code: CMI4186
Page number: 132
Formats: Excel and PDF
Industry: Pharmaceutical
- Historical Range : 2020 - 2024
- Base Year : 2025
- Estimated Year : 2026
- Forecast Period : 2026-2033

Table of Contents (Version-2026)

Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snippet, By Drug Type
  - Market Snippet, By Route of Administration
  - Market Snippet, By Distribution Channel
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Drivers
  - Restraints
  - Market Opportunities
- Impact Analysis
- Key Developments
- Epidemiology
- Merger, Acquisition, and Collaboration
- Regulatory Scenario
- PEST Analysis
U.S. Meibomian Gland Dysfunction Market, By Drug Type, 2021–2033 (US$ Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022–2033
  - Segment Trends
- Cyclosporine
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Mn)
- Omega-3 supplements
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Mn)
- Omega-3 supplements
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Mn)
- Antibacterial Eye Drops
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Mn)
- Steroids
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Mn)
- AZR MD 001
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Mn)
- TP 03
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Mn)
- NOV03 (Novatears)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Mn)
- HY02–Minocycline
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Mn)
U.S. Meibomian Gland Dysfunction Market,

By Route of Administration, 2021–2033 (US$ Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022–2033
  - Segment Trends
- Oral
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Mn)
- Topical
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Mn)
U.S. Meibomian Gland Dysfunction Market,

By Distribution Channel, 2021–2033 (US$ Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022–2033
  - Segment Trends
- Hospital Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Mn)
- Retail Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Mn)
- Online Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Mn)
Competitive Landscape
- Company Profiles
  - Pfizer, Inc.*
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - AbbVie Inc.
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Johnson and Johnson Vision Care Inc.
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Bausch Health Companies Inc.
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Novartis AG
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Santen Pharmaceutical Co., Ltd.
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - I-MED Pharma Inc.
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - OASIS Medical
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Sentiss Pharma Pvt. Ltd.
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - RegeneRx
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Akorn, Inc.
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - AFT Pharmaceuticals
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Alcon Inc.
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Horus Pharma
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Mitotech
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Novaliq GmbH
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Otsuka Pharmaceutical Co. Ltd
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Prestige Consumer Healthcare
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Santen Pharmaceutical Co. Ltd
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Sun Pharmaceutical Industries Ltd
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - VISUfarma
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
Section
- References
- Research Methodology
- About us and Sales Contact

Get Instant Access - Buy Now

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now